Literature DB >> 27195818

Is it Fabry disease?

Raphael Schiffmann1, Maria Fuller2, Lorne A Clarke3, Johannes M F G Aerts4.   

Abstract

Fabry disease is caused by mutations in the GLA gene that lower α-galactosidase A activity to less than 25-30% of the mean normal level. Several GLA variants have been identified that are associated with relatively elevated residual α-galactosidase A. The challenge is to determine which GLA variants can cause clinical manifestations related to Fabry disease. Here, we review the various types of GLA variants and recommend that pathogenicity be considered only when associated with elevated globotriaosylceramide in disease-relevant organs and tissues as analyzed by mass spectrometry. This criterion is necessary to ensure that very costly and specific therapy is provided only when appropriate.Genet Med 18 12, 1181-1185.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27195818     DOI: 10.1038/gim.2016.55

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  27 in total

1.  MALDI imaging in Fabry nephropathy: a multicenter study.

Authors:  Vincenzo L'Imperio; Andrew Smith; Antonio Pisani; Maria D'Armiento; Viviana Scollo; Stefano Casano; Renato Alberto Sinico; Manuela Nebuloni; Antonella Tosoni; Federico Pieruzzi; Fulvio Magni; Fabio Pagni
Journal:  J Nephrol       Date:  2019-07-10       Impact factor: 3.902

2.  Proteinuria in a male adolescent with hearing loss: Answers.

Authors:  Gülşah Kaya Aksoy; Elif Çomak; Bahar Akkaya; Mustafa Koyun; Sema Akman
Journal:  Pediatr Nephrol       Date:  2017-11-02       Impact factor: 3.714

3.  GLA missense and promoter variants co-segregating in a Chinese family with Fabry disease.

Authors:  Zhe-Yi Dong; Qian Wang; Shu-Peng Lin; Pu Chen; Jiao-Na Liu; Shu-Wen Liu; Guang-Yan Cai; Xiang-Mei Chen; Quan Hong
Journal:  Ann Transl Med       Date:  2020-07

4.  Understanding and modifying Fabry disease: Rationale and design of a pivotal Phase 3 study and results from a patient-reported outcome validation study.

Authors:  Christoph Wanner; Virginia Kimonis; Juan Politei; David G Warnock; Nurcan Üçeyler; Aline Frey; Peter Cornelisse; Derralyn Hughes
Journal:  Mol Genet Metab Rep       Date:  2022-03-26

5.  Quantifying lysosomal glycosidase activity within cells using bis-acetal substrates.

Authors:  Samy Cecioni; Roger A Ashmus; Pierre-André Gilormini; Sha Zhu; Xi Chen; Xiaoyang Shan; Christina Gros; Matthew C Deen; Yang Wang; Robert Britton; David J Vocadlo
Journal:  Nat Chem Biol       Date:  2022-02-24       Impact factor: 16.174

6.  Quantitative evaluation of retinal and choroidal changes in Fabry disease using optical coherence tomography angiography.

Authors:  Zhongjing Lin; Xiaoxia Pan; Ke Mao; Qin Jiao; Yanwei Chen; Yisheng Zhong; Yu Cheng
Journal:  Lasers Med Sci       Date:  2021-01-06       Impact factor: 3.161

7.  Low frequency of Fabry disease in patients with common heart disease.

Authors:  Raphael Schiffmann; Caren Swift; Nathan McNeill; Elfrida R Benjamin; Jeffrey P Castelli; Jay Barth; Lawrence Sweetman; Xuan Wang; Xiaoyang Wu
Journal:  Genet Med       Date:  2017-10-26       Impact factor: 8.864

8.  Integrative Systems Biology Investigation of Fabry Disease.

Authors:  Marco Fernandes; Holger Husi
Journal:  Diseases       Date:  2016-11-15

9.  Newborn screening for Fabry disease in the north-west of Spain.

Authors:  Cristobal Colon; Saida Ortolano; Cristina Melcon-Crespo; Jose V Alvarez; Olalla E Lopez-Suarez; Maria L Couce; José R Fernández-Lorenzo
Journal:  Eur J Pediatr       Date:  2017-06-23       Impact factor: 3.183

10.  Fabry disease in the Spanish population: observational study with detection of 77 patients.

Authors:  Irene Vieitez; Olga Souto-Rodriguez; Lorena Fernandez-Mosquera; Beatriz San Millan; Susana Teijeira; Julian Fernandez-Martin; Felisa Martinez-Sanchez; Luis Jose Aldamiz-Echevarria; Monica Lopez-Rodriguez; Carmen Navarro; Saida Ortolano
Journal:  Orphanet J Rare Dis       Date:  2018-04-10       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.